title: Role of base-excision repair in the treatment of childhood acute lymphoblastic leukaemia with 6-mercaptopurine and high doses of methotrexate.
abstract: Methotrexate (MTX) and 6-mercaptopurine (6MP) are the most commonly used drugs in the therapy of childhood acute lymphoblastic leukaemia (ALL). The main genotoxic effect of MTX resulting from inhibition of thymidylate synthase is mis-incorporation of uracil into DNA, which is considered essential for the effectiveness of the Protocol M in ALL IC BFM 2002/EURO LB 2002 regimens. In this study, we investigated the level of basal and induced DNA damage as well as the effectiveness of DNA repair in lymphocytes of children with ALL at four time-points during therapy with MTX and 6MP. To assess DNA damage and the efficacy of DNA repair we used the modified alkaline comet assay with uracil DNA glycosylase (Udg) and endonuclease III (EndoIII). In addition, we examined the induction of apoptosis in the lymphocytes of the patients during treatment. Finally, we compared the activity of base-excision repair (BER), involved in removal of both uracil and oxidized bases from DNA in lymphocytes of children with ALL and lymphocytes of healthy children. BER efficiency was estimated in an in vitro assay with cellular extracts and plasmid substrates of heteroduplex DNA with an AP-site. Our results indicate that there is a significant decrease in the efficacy of DNA repair associated with an increased level of uracil in DNA and induction of apoptosis during therapy. Moreover, it was found that the BER capacity was decreased in the lymphocytes of ALL patients in contrast to that in lymphocytes of healthy children. Thus, we suggest that an impairment of the BER pathway may play a role in the pathogenesis and therapy of childhood ALL.
authors: Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Poland.
authors: M
authors: M
authors: Stanczyk
authors: T
authors: T
authors: Sliwinski
authors: J
authors: J
authors: Trelinska
authors: M
authors: M
authors: Cuchra
authors: L
authors: L
authors: Markiewicz
authors: L
authors: L
authors: Dziki
authors: A
authors: A
authors: Bieniek
authors: A
authors: A
authors: Bielecka-Kowalska
authors: M
authors: M
authors: Kowalski
authors: A
authors: A
authors: Pastorczak
authors: J
authors: J
authors: Szemraj
authors: W
authors: W
authors: Mlynarski
authors: I
authors: I
authors: Majsterek
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017209:Apoptosis; D002648:Child; D002675:Child, Preschool; D020552:Comet Assay; D004249:DNA Damage; D004260:DNA Repair; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage*; D010084:Oxidation-Reduction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D014498:Uracil / Q000378:metabolism; D055815:Young Adult
chemical_list: D014498:Uracil; D006861:Hydrogen Peroxide; D015122:Mercaptopurine; D008727:Methotrexate